**Core Concept**
Partner treatment is a crucial aspect of managing sexually transmitted infections (STIs) to prevent reinfection and reduce transmission to others. The decision to treat partners depends on the STI, its transmission dynamics, and the patient's sexual history.

**Why the Correct Answer is Right**
In the case of **Chlamydia trachomatis**, partner treatment is often recommended, especially in high-prevalence settings, due to the high risk of transmission and reinfection. This is because chlamydia can be asymptomatic and may not be detected in untreated partners, leading to ongoing transmission. The Centers for Disease Control and Prevention (CDC) guidelines support partner treatment for chlamydia to prevent long-term complications, such as pelvic inflammatory disease (PID) in women.

**Why Each Wrong Option is Incorrect**
**Option A:** Gonococcal infections (Neisseria gonorrhoeae) require partner treatment due to the high risk of transmission and the emergence of antibiotic-resistant strains.
**Option B:** Herpes simplex virus (HSV) treatment for partners is not always necessary, especially for genital herpes, as it is primarily a self-limiting condition. However, treatment may be recommended for recurrent outbreaks or to reduce transmission.
**Option C:** Human papillomavirus (HPV) treatment for partners is not typically necessary, as HPV is primarily a self-limiting condition. However, partner vaccination may be recommended for individuals at high risk of exposure.

**Clinical Pearl / High-Yield Fact**
When considering partner treatment, remember that it is essential to inform and educate patients about the importance of partner notification and treatment to prevent reinfection and transmission.

**Correct Answer: A. Gonococcal infections (Neisseria gonorrhoeae) require partner treatment due to the high risk of transmission and the emergence of antibiotic-resistant strains.